181 related articles for article (PubMed ID: 35987725)
1. The molecular and epidemiological characteristics of carbapenemase-producing Enterobacteriaceae isolated from children in Shanghai, China, 2016-2021.
Fu P; Luo X; Shen J; He L; Rong H; Li C; Chen S; Zhang L; Wang A; Wang C
J Microbiol Immunol Infect; 2023 Feb; 56(1):48-56. PubMed ID: 35987725
[TBL] [Abstract][Full Text] [Related]
2. Molecular characterization of carbapenem-resistant
Yan WJ; Jing N; Wang SM; Xu JH; Yuan YH; Zhang Q; Li AL; Chen LH; Zhang JF; Ma B; Ma Q; Li Y
J Med Microbiol; 2021 Mar; 70(3):. PubMed ID: 33587030
[No Abstract] [Full Text] [Related]
3. Phenotypic and Genotypic Characterization of Carbapenem-resistant Enterobacteriaceae: Data From a Longitudinal Large-scale CRE Study in China (2012-2016).
Wang Q; Wang X; Wang J; Ouyang P; Jin C; Wang R; Zhang Y; Jin L; Chen H; Wang Z; Zhang F; Cao B; Xie L; Liao K; Gu B; Yang C; Liu Z; Ma X; Jin L; Zhang X; Man S; Li W; Pei F; Xu X; Jin Y; Ji P; Wang H
Clin Infect Dis; 2018 Nov; 67(suppl_2):S196-S205. PubMed ID: 30423057
[TBL] [Abstract][Full Text] [Related]
4. [Comparison of the modified Hodge test and the Carba NP test for detection of carbapenemases in Enterobacteriaceae isolates].
Bayramoğlu G; Uluçam G; Gençoğlu Özgür Ç; Kılıç AO; Aydın F
Mikrobiyol Bul; 2016 Jan; 50(1):1-10. PubMed ID: 27058324
[TBL] [Abstract][Full Text] [Related]
5. Dissemination of Carbapenemases (KPC, NDM, OXA-48, IMP, and VIM) Among Carbapenem-Resistant
Han R; Shi Q; Wu S; Yin D; Peng M; Dong D; Zheng Y; Guo Y; Zhang R; Hu F;
Front Cell Infect Microbiol; 2020; 10():314. PubMed ID: 32719751
[TBL] [Abstract][Full Text] [Related]
6. Rapid Identification of OXA-48-like, KPC, NDM, and VIM Carbapenemase-Producing Enterobacteriaceae From Culture: Evaluation of the RESIST-4 O.K.N.V. Multiplex Lateral Flow Assay.
Song W; Park MJ; Jeong S; Shin DH; Kim JS; Kim HS; Kim HS; Lee N; Hong JS; Jeong SH
Ann Lab Med; 2020 May; 40(3):259-263. PubMed ID: 31858767
[TBL] [Abstract][Full Text] [Related]
7. [Investigation of carbapenemases in carbapenem-resistant Escherichia coli and Klebsiella pneumoniae strains isolated in 2014 in Turkey].
Çakar A; Akyön Y; Gür D; Karatuna O; Öğünç D; Özhak Baysan B; Çöplü N; Çağatay M; Kılıç A; Baysallar M; Bakıcı Z; Çelik C; Gülay Z; Aydemir Ş; Tünger A; Kılıç H; Erçal BD; Aşçı Toraman Z; Zer Y; Büyüktaş A; Ay S; Aktaş Z; Kayacan Ç; Bayramoğlu G; Aydın F; Dündar D; Hasdemir U; Ayaş R; Yanık K; Günaydın M; Güdücüoğlu H; Parlak M
Mikrobiyol Bul; 2016 Jan; 50(1):21-33. PubMed ID: 27058326
[TBL] [Abstract][Full Text] [Related]
8. CARB-ES-19 Multicenter Study of Carbapenemase-Producing
Cañada-García JE; Moure Z; Sola-Campoy PJ; Delgado-Valverde M; Cano ME; Gijón D; González M; Gracia-Ahufinger I; Larrosa N; Mulet X; Pitart C; Rivera A; Bou G; Calvo J; Cantón R; González-López JJ; Martínez-Martínez L; Navarro F; Oliver A; Palacios-Baena ZR; Pascual Á; Ruiz-Carrascoso G; Vila J; Aracil B; Pérez-Vázquez M; Oteo-Iglesias J;
Front Microbiol; 2022; 13():918362. PubMed ID: 35847090
[TBL] [Abstract][Full Text] [Related]
9. Genotypic Distribution and Antimicrobial Susceptibilities of Carbapenemase-Producing
Jeong S; Lee N; Park MJ; Jeon K; Kim HS; Kim HS; Kim JS; Song W
Ann Lab Med; 2022 Jan; 42(1):36-46. PubMed ID: 34374347
[TBL] [Abstract][Full Text] [Related]
10. Activity of ceftazidime-avibactam against carbapenemase-producing Enterobacteriaceae from urine specimens obtained during the infection-carbapenem resistance evaluation surveillance trial (iCREST) in Spain.
García-Castillo M; García-Fernández S; Gómez-Gil R; Pitart C; Oviaño M; Gracia-Ahufinger I; Díaz-Regañón J; Tato M; Cantón R;
Int J Antimicrob Agents; 2018 Mar; 51(3):511-515. PubMed ID: 29371104
[TBL] [Abstract][Full Text] [Related]
11. Characterization of Carbapenem-Resistant Enterobacteriaceae Clinical Isolates in Al Thawra University Hospital, Sana'a, Yemen.
Alsharapy SA; Gharout-Sait A; Muggeo A; Guillard T; Cholley P; Brasme L; Bertrand X; Moghram GS; Touati A; De Champs C
Microb Drug Resist; 2020 Mar; 26(3):211-217. PubMed ID: 31397629
[No Abstract] [Full Text] [Related]
12. Molecular epidemiology and drug resistant mechanism in carbapenem-resistant Klebsiella pneumoniae isolated from pediatric patients in Shanghai, China.
Zhang X; Chen D; Xu G; Huang W; Wang X
PLoS One; 2018; 13(3):e0194000. PubMed ID: 29558475
[TBL] [Abstract][Full Text] [Related]
13. Prevalence and Characteristics of Carbapenemase-Producing Enterobacteriaceae in Three Tertiary-Care Korean University Hospitals between 2017 and 2018.
Kim SH; Kim GR; Jeong J; Kim S; Shin JH
Jpn J Infect Dis; 2020 Nov; 73(6):431-436. PubMed ID: 32475870
[TBL] [Abstract][Full Text] [Related]
14. First description of NDM-1-, KPC-2-, VIM-2- and IMP-4-producing Klebsiella pneumoniae strains in a single Chinese teaching hospital.
Liu Y; Wan LG; Deng Q; Cao XW; Yu Y; Xu QF
Epidemiol Infect; 2015 Jan; 143(2):376-84. PubMed ID: 24762211
[TBL] [Abstract][Full Text] [Related]
15. Characterization of carbapenemase-producing Enterobacteriaceae from colonized patients in a university hospital in Madrid, Spain, during the R-GNOSIS project depicts increased clonal diversity over time with maintenance of high-risk clones.
Hernández-García M; Pérez-Viso B; Carmen Turrientes M; Díaz-Agero C; López-Fresneña N; Bonten M; Malhotra-Kumar S; Ruiz-Garbajosa P; Cantón R
J Antimicrob Chemother; 2018 Nov; 73(11):3039-3043. PubMed ID: 30053018
[TBL] [Abstract][Full Text] [Related]
16. [The genotype and epidemiological feature of the Enterobacteriaceae carrying carbapenemase in China].
Zhang J; Liu Y; Chen H; Cao B; Gao H; Li H; Wang H
Zhonghua Nei Ke Za Zhi; 2014 Feb; 53(2):116-20. PubMed ID: 24767163
[TBL] [Abstract][Full Text] [Related]
17. Epidemiology and in vitro activity of ceftazidime-avibactam, meropenem-vaborbactam, imipenem-relebactam, eravacycline, plazomicin, and comparators against Greek carbapenemase-producing Klebsiella pneumoniae isolates.
Maraki S; Mavromanolaki VE; Magkafouraki E; Moraitis P; Stafylaki D; Kasimati A; Scoulica E
Infection; 2022 Apr; 50(2):467-474. PubMed ID: 34854060
[TBL] [Abstract][Full Text] [Related]
18. Carbapenemase-producing Enterobacteriaceae in South Korea: a report from the National Laboratory Surveillance System.
Yoon EJ; Yang JW; Kim JO; Lee H; Lee KJ; Jeong SH
Future Microbiol; 2018 Jun; 13():771-783. PubMed ID: 29478336
[TBL] [Abstract][Full Text] [Related]
19. Carbapenemase-producing enterobacteriaceae in Spain in 2012.
Oteo J; Saez D; Bautista V; Fernández-Romero S; Hernández-Molina JM; Pérez-Vázquez M; Aracil B; Campos J;
Antimicrob Agents Chemother; 2013 Dec; 57(12):6344-7. PubMed ID: 24041898
[TBL] [Abstract][Full Text] [Related]
20. Molecular epidemiology of clinical isolation of carbapenem-resistant Enterobacterales and application of carbapenemase inhibitor enhancement test.
Li H; Zhong Y; Yan Q; Liu W; Liang X
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 Aug; 48(8):1210-1216. PubMed ID: 37875361
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
